FMCG · Labeling law: why the back of the pack is a legal minefield
In 2015, the US Food and Drug Administration (FDA) sent Kind LLC a warning letter. Kind's fruit and nut bars said "healthy" on the label, and the FDA said they couldn't, because nuts pushed saturated fat above the agency's 1990s-era threshold for that word. Kind petitioned the FDA, and in 2016 the agency let the company keep the language as a statement of philosophy. Then it reopened the definition of "healthy" entirely. That process took almost a decade and ended with a new federal rule in December 2024. One adjective on one snack bar helped rewrite a national standard.
This is the back of the pack: a few square inches of text that carries more legal exposure than most of a company's marketing budget.
Why the label is a legal document, not a design asset
Marketing teams treat packaging as a canvas. Legal and regulatory affairs teams treat it as a filing. Both are right, and that is the problem.
Every claim on a label (nutrition content, health benefits, origin, "natural," "sustainable") is a factual assertion that a regulator can test against a legal standard. If the wording, the substantiation or the formatting is wrong, the label becomes evidence in a case.
Two regulatory systems dominate this space for any company selling into the US or EU:
- FDA and FTC (US): The FDA regulates what nutrition and health information must appear and how it's formatted. The Federal Trade Commission (FTC) regulates whether marketing claims are truthful and substantiated, including claims made off-label, in ads or on social media.
- EU Food Information to Consumers Regulation (FIC, EU No 1169/2011): A single EU-wide rule on mandatory nutrition declarations, allergen labeling and country-of-origin rules, enforced by national food safety authorities in each member state. The UK kept a near-identical retained version after Brexit, enforced by the Food Standards Agency (FSA).
What the rules actually require
Nutrition panels
In the US, the FDA's Nutrition Facts Label format is prescribed down to font size and line spacing (21 CFR 101.9). The 2016 update (fully phased in by 2021) added "Added Sugars" as a mandatory line, which pushed brands across the packaged food aisle to reformulate or disclose.
The next change is on the front of the pack. In January 2025 the FDA proposed a mandatory "Nutrition Info box" rating saturated fat, sodium and added sugars as Low, Med or High. Brands planning packaging cycles should track it on the FDA's front-of-package page.
In the EU, FIC requires a nutrition declaration of seven items: energy, fat, saturates, carbohydrates, sugars, protein and salt, per 100g or 100ml. Front-of-pack schemes like France's Nutri-Score (a letter grade from A to E) are voluntary at EU level, but retailers in markets like France, Belgium and Spain often expect them.
Ingredient lists
Both systems require ingredients in descending order by weight, and both require allergen disclosure. The EU mandates that 14 specific allergens be emphasized (bold, underlined or a different font) inside the ingredient list itself, not in a separate box. In the US, the FASTER Act (2021) added sesame as the ninth major allergen, effective January 2023.
Miss an allergen and you're looking at a recall, not a fine. Undeclared allergens are consistently the leading cause of US food recalls listed in the FDA's recall database.
Health and nutrient content claims
This is where most litigation lives. The FDA sets criteria for terms like "low fat," "light" and "healthy." Its updated "healthy" rule, finalized in December 2024 and effective in 2025, drops the old total-fat logic. A product now has to contain a meaningful amount of at least one food group (fruit, vegetables, grains, dairy, protein foods) and stay under limits for added sugars, sodium and saturated fat. Nuts, seeds, salmon and olive oil can now qualify. Many sweetened cereals and yogurts no longer can. Companies have until February 2028 to comply.
"Natural" is different: the FDA still has no formal definition, which keeps it a favorite target for consumer lawsuits. The FTC separately requires that any health claim be backed by "competent and reliable scientific evidence" before it reaches the package.
The EU's Nutrition and Health Claims Regulation (EC 1924/2006) is stricter. A claim like "supports immune function" can only be used if that specific wording is in the EU Register of authorized health claims. Unauthorized claims are illegal by default, with no case-by-case argument.
When labeling turns into litigation
The US has a distinctive risk multiplier: class actions under state consumer protection laws, with California's Unfair Competition Law the most used. Plaintiffs' firms watch for phrases like "natural," "no added sugar" or "made with real fruit" that don't match the ingredient list.
Some pattern cases:
- Vanilla flavor lawsuits: From 2019 onward, hundreds of suits targeted products labeled "vanilla" whose flavor came partly from non-bean sources. Most were dismissed, because courts found reasonable consumers read "vanilla" as a flavor, not a sourcing promise. Defending them still cost brands legal fees and management time.
- POM Wonderful v. FTC (2015): POM's ads claimed its juice could help treat heart disease and prostate cancer. A federal appeals court upheld the FTC's order, confirming that disease claims need randomized clinical evidence, not consumer perception.
- Kind "all natural" class action: Consumers sued Kind over "all natural" and "non-GMO" claims. After years of litigation, a federal court granted Kind summary judgment in 2022, partly because plaintiffs could not show a workable definition of "natural." Kind won, but only after about seven years.
In the EU, enforcement runs mostly through national authorities rather than private class actions. The financial result is similar: recalls, forced relabeling across a whole SKU range, and reputational damage that lasts longer than any fine.
A worked example: the cost of one wrong word
Assume a mid-size snack brand sells 5 million units a year of a bar labeled "healthy" that no longer qualifies under the 2024 rule and must be reformulated or relabeled.
- Packaging redesign and artwork updates across formats: estimate $150,000 to $400,000 (design, prepress, plate changes across SKUs and languages).
- Relabeling existing inventory: 2 months of stock is about 830,000 units. At $0.05 per unit, that is roughly $41,500.
- Legal defense and settlement if a class action follows: publicly reported FMCG label settlements have ranged from about $1 million to over $10 million depending on class size and claim. These are illustrative ranges, not a specific case.
The low end of packaging plus relabeling alone is about $190,000, before any lawyer gets involved. For a single word.
Knowledge check
1. What does the Kind LLC 'healthy' labeling case illustrate about front-of-pack marketing claims?
2. Why does the lesson describe the back of a product pack as a legal document rather than just a design asset?
3. A US company wants to run a social media ad claiming its snack 'boosts energy,' a claim not printed on the physical label. Which regulatory body's jurisdiction is most directly relevant to this claim?
4. Select ALL correct answers about the distinction between FDA and FTC roles in US food labeling regulation.
Select all the correct answers.
5. Select ALL correct answers about the EU Food Information to Consumers Regulation (FIC).
Select all the correct answers.
Who enforces what, in practice
| Body | Jurisdiction | Core power |
|---|---|---|
| FDA | US | Sets label format and content rules, can seize products, issue warning letters |
| FTC | US | Polices truthfulness of claims across all marketing, not just labels |
| State AGs / class action bar | US | Civil litigation under consumer protection laws, often the real financial risk |
| National food safety authorities (per EU member state) | EU | Enforce FIC and health claims regulation, coordinate recalls |
| European Food Safety Authority (EFSA) | EU | Scientifically evaluates health claims before the European Commission authorizes them |
The practical lesson for anyone in FMCG: legal, regulatory affairs and marketing should sign off on labels jointly, before print. Kind's experience shows the alternative. A warning letter, a citizen petition and a seven-year class action all traced back to words on a wrapper. Reformulating to legitimately meet a claim's criteria is usually cheaper than defending a claim that doesn't.
🎬 [VIDEO: "How Food Labels Are Regulated (and Often Misleading)" - https://www.youtube.com/results?search_query=FDA+healthy+claim+rule+food+label+regulation - search for current explainer content from consumer-focused or regulatory-affairs channels covering the FDA's updated "healthy" rule and FDA/FTC label enforcement]
Key Takeaways
- Nutrition panels are format-prescribed (21 CFR 101.9 in the US, FIC Regulation 1169/2011 in the EU). Getting the layout or mandatory nutrients wrong is a violation regardless of intent.
- The FDA's "healthy" definition changed in December 2024, with compliance due by February 2028. Products using the word need to be rechecked against the new food-group and nutrient limits.
- Health claims are the highest-risk zone. The EU requires pre-authorized wording from the Register, while the US relies on FDA definitions, FTC substantiation and an active plaintiffs' bar. "Natural" still has no FDA definition.
- Undeclared allergens are the leading cause of US food recalls, and the EU requires allergens to be emphasized in the ingredient list.
- Pre-launch sign-off by legal, regulatory and marketing costs far less than relabeling, recalls or years of litigation, even litigation you eventually win.